In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation

Biochemical Journal

Volumn 398, Issue 3, 2006, Pages 509-514

  Pecora, Fabio ^a   Gualeni, Benedetta ^a   Forlino, Antonella ^a   Superti Furga, Andrea ^b   Tenni, Ruggero ^a   Cetta, Giuseppe ^a   Rossi, Antonio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Amino acid sulfur; Cartilage; Diastrophic dysplasia sulfate transporter; Glycosaminoglycan; N acetyl L cysteine; Proteoglycan

Indexed keywords

BODY FLUIDS; CARTILAGE; CYTOLOGY; DRUG PRODUCTS; MUTAGENESIS; OXIDATION; SULFUR COMPOUNDS;

AMINO ACID SULFUR; CATABOLISM; DIASTROPHIC DYSPLASIA SULFATE TRANSPORTER; GLYCOSAMINOGLYCAN; N-ACETYL-L-CYSTEINE; PROTEOGLYCAN; PROTEOGLYCAN SULFATION;

AMINO ACIDS;

ACETYLCYSTEINE; AMINO ACID; CYSTINE; PROTEOGLYCAN; ANION TRANSPORT PROTEIN; CARRIER PROTEIN; SLC26A2 PROTEIN, MOUSE; SULFATE; SULFUR; THIOL DERIVATIVE;

ARTICLE; CARTILAGE; CONTROLLED STUDY; DYSPLASIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SULFATION; AMINO ACID SUBSTITUTION; ANIMAL; CHEMISTRY; CHO CELL; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; METABOLISM; MUTATION; TRANSGENIC MOUSE;

DELLA; PECORA;

ACETYLCYSTEINE; AMINO ACID SUBSTITUTION; AMINO ACIDS; ANIMALS; ANION TRANSPORT PROTEINS; CARRIER PROTEINS; CARTILAGE; CHO CELLS; CRICETINAE; GENE EXPRESSION REGULATION; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; PROTEOGLYCANS; SULFATES; SULFHYDRYL COMPOUNDS; SULFUR;

EID: 33748755041     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20060566     Document Type: Article

References (32)

1. Iozzo, R. V. (1998) Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67, 609-652
2. Habuchi, O. (2000) Diversity and functions of glycosaminoglycan sulfotransferases. Biochim. Biophys. Acta 1474, 115-127
3. Klaassen, C. D. and Boles, J. W. (1997) Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-hosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11, 404-418
4. Hirschberg, C. B., Robbins, P. W. and Abeijon, C. (1998) Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. Annu. Rev. Biochem. 67, 49-69
5. Superti-Furga, A. (2001) Defects in sulfate metabolism and skeletal dysplasias. In The Metabolic and Molecular Bases of Inherited Disease, 8th edn (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Vogelstein, B. and Childs, B., eds.), pp. 5189-5201, McGraw-Hill, New York
6. Rossi, A. and Superti-Furga, A. (2001) Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance. Hum. Mutat. 17, 159-171
7. Erratum (2001) Hum. Mutat. 18, 82
8. ul Haque, M. F., King, L. M., Krakow, D., Cantor, R. M., Rusiniak, M. E., Swank, R. T., Superti-Furga, A., Haque, S., Abbas, H., Ahmad, W. et al. (1998) Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nat. Genet. 20, 157-162
9. Kurima, K., Warman, M. L., Krishnan, S., Domowicz, M., Krueger, Jr, R. C., Deyrup, A. and Schwartz, N. B. (1998) A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proc. Natl. Acad. Sci. U.S.A. 95, 8681-8685
10. Erratum (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 12071
11. 2- concentration. J. Biol. Chem. 257, 917-923
12. Humphries, D. E., Silbert, C. K. and Silbert, J. E. (1988) Sulfation by cultured cells. Cysteine, cysteinesulfinic acid and sulfite as sources for proteoglycan sulfate. Biochem. J. 252, 305-308
13. Esko, J. D., Elgavish, A., Prasthofer, T., Taylor, W. H. and Weinke, J. L. (1986) Sulfate transport-deficient mutants of Chinese hamster ovary cells. Sulfation of glycosaminoglycans dependent on cysteine. J. Biol. Chem. 261, 15725-15733
14. 2- and sulfur-containing amino acids as sources for macromolecular sulfation. Am. J. Physiol. 260, L450-L456
15. Keller, J. M. and Keller, K. M. (1987) Amino acid sulfur as a source of sulfate for sulfated proteoglycans produced by Swiss mouse 3T3 cells. Biochim. Biophys. Acta 926, 139-144
16. Hästbacka, J., de la, C. A., Mahtani, M. M., Clines, G., Reeve Daly, M. P., Daly, M., Hamilton, B. A., Kusumi, K., Trivedi, B., Weaver, A. et al. (1994) The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 78, 1073-1087
17. Rossi, A., Bonaventure, J., Delezoide, A. L., Superti-Furga, A. and Cetta, G. (1997) Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2. Eur. J. Biochem. 248, 741-747
18. Rossi, A., Cetta, A., Piazza, R., Bonaventure, J., Steinmann, B. and Superti-Furga, A. (2003) In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias. Pediatr. Pathol. Mol. Med. 22, 311-321
19. Forlino, A., Piazza, R., Tiveron, C., Delia Torre, S., Tatangelo, L., Bonafe, L., Gualeni, B., Romano, A., Pecora, F., Superti-Furga, A. et al. (2005) A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum. Mol. Genet. 14, 859-871
20. Rizzo, V., Montalbetti, L., Valli, M., Bosoni, T., Scoglio, E. and Moratti, R. (1998) Study of factors affecting the determination of total plasma 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate (SBD)-thiol derivatives by liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 706, 209-215
21. Accinni, R., Campolo, J., Bartesaghi, S., De Leo, G., Lucarelli, C., Cursano, C. F. and Parodi, O. (1998) High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards. J. Chromatogr. A 828, 397-400
22. Tsikas, D., Sandmann, J., Ikic, M., Fauler, J., Stichtenoth, D. O. and Frolich, J. C. (1998) Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine. J. Chromatogr. B Biomed. Sci. Appl. 708, 55-60
23. Rome, L. H. and Hill, D. F. (1986) Lysosomal degradation of glycoproteins and glycosaminoglycans. Efflux and recycling of sulfate and N-acetylhexosamines. Biochem. J. 235, 707-713
24. Harper, G. S., Rozaklis, T., Bielicki, J. and Hopwood, J. J. (1993) Lysosomal sulfate efflux following glycosaminoglycan degradation: measurements in enzyme-supplemented Maroteaux-Lamy syndrome fibroblasts and isolated lysosomes. Glycoconj. J. 10, 407-415
25. Imai, Y., Yanagishita, M. and Hascall, V. C. (1994) Measurement of contribution from intracellular cysteine to sulfate in phosphoadenosine phosphosulfate in rat ovarian granulosa cells. Arch. Biochem. Biophys. 312, 392-400
26. Kim, H. J., Madhu, C., Cho, J. H. and Klaassen, C. D. (1995) In vivo modification of 3′-phosphoadenosine 5′-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine. Drug Metab. Dispos. 23, 840-845
27. Dominy, Jr, J. E., Hirschberger, L. L., Coloso, R. M. and Stipanuk, M. H. (2006) Regulation of cysteine dioxygenase degradation is mediated by intracellular cysteine levels and the ubiquitin-26 S proteasome system in the living rat. Biochem. J. 394, 267-273
28. Lehmann, A., Hagberg, H., Orwar, O. and Sandberg, M. (1993) Cysteine sulfinate and cysteate: mediators of cysteine toxicity in the neonatal rat brain? Eur. J. Neurosci. 5, 1398-1412
29. Heafield, M. T., Fearn, S., Steventon, G. B., Waring, R. H., Williams, A. C. and Sturman, S. G. (1990) Plasma cysteine and sulfate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci. Lett. 110, 216-220
30. Ozkan, Y., Ozkan, E. and Simsek, B. (2002) Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int. J. Cardiol. 82, 269-277
31. Iwata, F., Kuehl, E. M., Reed, G. F., McCain, L. M., Gahl, W. A. and Kaiser-Kupfer, M. I. (1998) A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis. Mol. Genet. Metab. 64, 237-242
32. Moldeus, P. and Cotgreave, I. A. (1994) N-Acetylcysteine. Methods Enzymol. 234, 482-492